By upregulating the expression level of NS5ATP9, TAF efficiently improved BLM-induced lung fibrosis by inhibiting the differentiation of fibroblasts into myofibroblasts and increasing ECM production as well as the expression of phosphorylated-Smad3, among other proteins. The gene discussed is PCLAF; the disease is pulmonary fibrosis.